PRODUCTION AND APPLICATION OF ARYLALKYL DERIVATIVE ACIDS FOR OBESITY TREATMENT Russian patent published in 2009 - IPC C07D235/30 C07D277/82 C07D277/42 C07D277/58 C07D263/58 A61K31/4184 A61K31/423 A61K31/428 A61K31/426 A61P3/04 

Abstract RU 2357959 C2

FIELD: chemistry.

SUBSTANCE: invention refers to new compounds of formula (I) and its pharmaceutically acceptable salts and esters. Compounds of the present invention are characterised with properties of DGAT-1 inhibitor. In general formula (I) , Q represents O, S or NR5; A represents a linker chosen from where p is equal to 1 or 2, and , where m is equal to 0, and n is equal to 1, 2, 3 or 4, or m is equal to 1, while n is equal to 1, 2 or 3, where specified linker is optionally substituted with one or two groups R8; R1 and R2 are independently chosen from hydrogen, haloid; R3 is chosen from hydrogen, (C1-C6)alkyl optionally substituted with hydroxyl and phenyl optionally substituted with haloid; R4 is chosen from hydrogen, nitro and (C1-C6)alkyl; or R3 and R4 together with carbon atoms whereto attached, can form benzene ring optionally substituted with 1-2 substitutes. The invention also concerns compounds of formula (Ia) and (Ib) with structural formulas presented in the patent claim, and also to a pharmaceutical composition, a medical product, to application of compounds for making a medical product and compound process.

EFFECT: new compounds possess useful biological activity.

19 cl, 2 tbl, 7 dwg, 215 ex

Similar patents RU2357959C2

Title Year Author Number
BENZOTHIAZOLE INHIBITORS OF PROTEIN TYROSINE KINASES 1998
  • Das Dzhagabandkhu
  • Behrrish Dzhoel S.
  • Vitjak Dzhon
RU2212407C2
PRODRUG 1,3-DIAMINO-2-HYDROXYPROPANE DERIVATIVES 2003
  • Fobian Ivett M.
  • Freskos Dzhon N.
  • Jagodzinska Barbara
RU2357962C2
NEW COMPOUNDS 2007
  • Serrano-Vu Majkl Kh.
  • Kvak En-Sin
  • Lju Vehn'Min
RU2456273C2
NOVEL COMPOUNDS AND FASN INHIBITION COMPOSITIONS 2014
  • Bair, Kenneth, W.
  • Lancia, David, R.
  • Li, Hongbin
  • Loch, James
  • Lu, Wei
  • Martin, Matthew, W.
  • Millan, David, S.
  • Schiller, Shawn, E.R.
  • Tebbe, Mark, J.
RU2737434C2
METHOD OF RESIDUAL LIPOPROTEINS PRODUCING INHIBITION 2004
  • Okamoto Khirosi
  • Furukava Noboru
  • Sasase Tomokhiko
RU2330682C2
(HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS 2012
  • Ortega-Munos Alberto
  • Fajf Mattyu Kolin Tor
  • Martinell-Pedemonte Mark
  • Estyarte-Martines Mariya-De-Los-Ankheles
  • Valls-Vidal Nuriya
  • Kurts Guido
  • Kastro-Palomino-Lariya Khulio-Sesar
RU2681211C2
SUBSTITUTED THIOPHENECARBOXAMIDES AND ANALOGUES AS ANTIBACTERIAL AGENTS 2019
  • Bernier, David
  • Brunet, Stephane
  • Dufour, Jeremy
  • Knobloch, Thomas
  • Nicolas, Lionel
  • Tsuchiya, Tomoki
RU2797316C2
BENZOTHIAZOLE CYCLOBUTYL AMINE DERIVATIVES AS LIGANDS OF HISTAMINE H-RECEPTORS, PHARMACEUTICAL COMPOSITION BASED THEREON, METHOD FOR SELECTIVE MODULATION OF EFFECTS OF HISTAMINE H-RECEPTORS AND METHOD OF TREATING CONDITION OR DISORDER MODULATED BY HISTAMINE H-RECEPTORS 2006
  • Kauehrt Marlon D.
  • San Minkhua
  • Chzhao Chehn'
  • Chzhehn Go Chzhu
RU2487130C2
NOVEL PYRAZINE DERIVATIVES 2012
RU2612138C2
DERIVANTS OF BICYCLO[2, 2, 1] HEPT-7-YLAMINE AND THEIR APPLICATIONS 2006
  • Finch Garri
  • Rehj Nikolas Charl'Z
  • Bull Richard Dzhejms
  • Van Nil Monik Bodil
  • Dzhenningz Ehndrju Stefen Robert
RU2442771C2

RU 2 357 959 C2

Authors

Smit Rodzher

Kehmpbell Ehnn-Mehri

Kojsh Filip

Dehj Miao

Dzhenkins S'Juzen

Louvi Derek

O Konnor Stiven

Su Ning

Vang Gan

Zhang Mingbao

Zhu Lej

Dates

2009-06-10Published

2004-05-06Filed